Olympus Corp.'s Fiscal Year is From April To March.
The item "Enterprise-Value-To-Ebitda-Ratio" stands at 13.43 as of 09/30/2025.
As of the end of Olympus Corp.'s second quarter, the item "Enterprise Value To Ebitda Ratio" stands at 13.43. This represents an increase of 83.78 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -18.49 percent compared to the value the year prior.
The 1 year change in percent is -18.49.
The 3 year change in percent is 8.02.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Enterprise Value To Ebitda Ratio | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Enterprise Value To Ebitda Ratio | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Enterprise Value To Ebitda Ratio | 172,241,486,586.05 |
![]() | Danaher Corporation - Enterprise Value To Ebitda Ratio | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Enterprise Value To Ebitda Ratio | 144,567,730,176.00 |